NYKODE THERAPEUTICS ASA financial statements, including revenue, expenses, profit, and loss

The total revenue of 5VB for the last quarter is 487.12 k EUR, and it's 4.72% lower compared to the previous quarter. The net income of Q3 24 is -8.84 M EUR.